Nexstim appoints Ville Saarainen as CTO effective April 1, 2027

By Public Technologies
  • Nexstim appointed Ville Saarainen chief technology officer, effective April 1, 2027.
  • Saarainen will lead R&D, join the management team and report directly to the CEO.
  • He most recently served as CTO at Evondos, following R&D roles at Thermo Fisher Scientific, ultimately leading clinical diagnostics systems R&D.
  • Gustaf Järnefelt will retire as vice president of R&D, effective March 31, 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexstim Oyj published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk